March 2024: Revolution in Diabetes, Painless Smartpatch

Medicsen revolutionizes diabetes treatment with a painless Smartpatch.

Image credits: Medicsensors S.L

In the ever-evolving field of healthcare technology, Medicsen emerges as a bold innovator, shaping the future for people living with diabetes. Driven by the desire to eliminate the pain and inconvenience associated with traditional diabetes management, Medicsen has developed a revolutionary solution: the Medicsen Smartpatch.

Imagine, a world where managing diabetes is painless, discreet, and personalized. The Medicsen Smartpatch makes this vision a reality. This needle-free, wearable device acts as a smart companion, simulating the functions of the pancreas and delivering essential medications directly through the skin.

Utilizing harmless waves, the Smartpatch painlessly opens natural skin pores, allowing macromolecules like insulin and heparin to enter the body. This innovative technology ensures maximum comfort and discretion, tucked away in a small, wearable device.

Image credits: Medicsensors S.L

About Medicsen

Medicsen was founded in 2023 and has quickly developed into an award-winning start-up in the field of medical technology. The company specializes in pain-free drug delivery through the skin and wearable devices for patients with chronic diseases. The company focuses on developing user-friendly and pain-free solutions for a better quality of life.

Sam Draper
March 1, 2024

March 2024

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Wearables Playing Crucial Role In Patient Monitoring During COVID-19 Pandemic

Wearable technologies can be innovative solutions for healthcare problems

Physical Activity and Wearables – Prevention, Treatment and Rehabilitation

By providing patients with an instant biofeedback, wearables not only have the possibility...

Global Medical Wearables Market Size to Reach US $85.6 Billion by 2027: Polaris Market Research

The global Wearable Medical Devices market size is expected to reach USD 85.6 billion by 2027...

Apple Watch Glucose Tracker Reaches Proof-Of-Concept

Apple reached the proof-of-concept stage of noninvasive blood glucose monitoring technology.
Discover more